Importer of Controlled Substances; Notice of Registration, 31313-31314 [E9-15443]

Download as PDF Federal Register / Vol. 74, No. 124 / Tuesday, June 30, 2009 / Notices 31313 company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with State and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic classes of controlled substances listed. Schedule Drug Schedule sroberts on PROD1PC70 with NOTICES6 4-Bromo-2,5dimethoxyphenethylamine (7392). 4-Methyl-2,5dimethoxyamphetamine (7395). 2,5-Dimethoxyamphetamine (7396). 2,5-Dimethoxy-4ethylamphetamine (7399). 3,4-Methylenedioxyamphetamine (7400). 3,4-Methylenedioxy-Nethylamphetamine (7404). 3,4Methylenedioxymethamphetamine (7405). 4-Methoxyamphetamine (7411) .... Dimethyltryptamine (7435) ............ Psilocybin (7437) .......................... Psilocyn (7438) ............................. N-Benzylpiperazine (7493) ........... Acetyldihydrocodeine (9051) ........ Dihydromorphine (9145) ............... Heroin (9200) ................................ Normorphine (9313) ...................... Pholcodine (9314) ......................... Tilidine (9750) ............................... 3-Methylfentanyl (9813) ................ Amphetamine (1100) .................... Methamphetamine (1105) ............. Methylphenidate (1724) ................ Amobarbital (2125) ....................... Pentobarbital (2270) ..................... Secobarbital (2315) ...................... Phencyclidine (7471) .................... Phenylacetone (8501) ................... Cocaine (9041) ............................. Codeine (9050) ............................. Dihydrocodeine (9120) ................. Oxycodone (9143) ........................ Hydromorphone (9150) ................. Benzoylecgonine (9180) ............... Ethylmorphine (9190) ................... Hydrocodone (9193) ..................... Levorphanol (9220) ....................... Meperidine (9230) ......................... Methadone (9250) ........................ Dextropropoxyphene, bulk. (non-dosage forms) (9273) ........... Morphine (9300) ........................... Thebaine (9333) ........................... Oxymorphone (9652) .................... Alfentanil (9737) ............................ Sufentanil (9740) .......................... Fentanyl (9801) ............................. I I I I I I I Dated: June 23, 2009. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E9–15445 Filed 6–29–09; 8:45 am] I I I I I I I I I I I I II II II II II II II II II II II II II II II II II II II BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration By Notice dated February 23, 2009, and published in the Federal Register on March 2, 2009 (74 FR 9107), Sigma Aldrich Manufacturing LLC., 3500 Dekalb Street, St. Louis, Missouri 63118, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in schedules I and II: Drug II II II II II II II The company plans to import analytical reference standards for distribution to its customers for research and analytical purposes. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Lipomed, Inc. to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Lipomed, Inc. to ensure that the VerDate Nov<24>2008 19:55 Jun 29, 2009 Jkt 217001 Schedule Cathinone (1235) .......................... Methcathinone (1237) ................... Aminorex (1585) ........................... Gamma Hydroxybutyric Acid (2010). Methaqualone (2565) .................... Alpha-ethyltryptamine (7249) ........ Ibogaine (7260) ............................. Lysergic acid diethylamide (7315) Marihuana (7360) ......................... Tetrahydrocannabinols (7370) ...... Mescaline (7381) .......................... 4-Bromo-2,5dimethoxyamphetamine (7391). 4-Bromo-2,5dimethoxyphenethylamine (7392). 4-Methyl-2,5dimethoxyamphetamine (7395). 2,5-Dimethoxyamphetamine (7396). 3,4-Methylenedioxyamphetamine (7400). N-Hydroxy-3,4methylenedioxyamphetamine (7402). 3,4-Methylenedioxy-Nethylamphetamine (7404). PO 00000 Frm 00078 Fmt 4703 Sfmt 4703 I I I I I I I I I I I I I I I I I I Drug 3,4Methylenedioxymethamphetamine (MDMA) (7405). 4-Methoxyamphetamine (7411) .... Bufotenine (7433) ......................... Diethyltryptamine (7434) ............... Dimethyltryptamine (7435) ............ Psilocybin (7437) .......................... Psilocyn (7438) ............................. 1-[1-(2Thienyl)cyclohexyl]piperdine (7470). N-Benzylpiperazine (BZP) (7493) Heroin (9200) ................................ Normorphine (9313) ...................... Etonitazene (9624) ....................... Amphetamine (1100) .................... Methamphetamine (1105) ............. Methylphenidate (1724) ................ Amobarbital (2125) ....................... Pentobarbital (2270) ..................... Secobarbital (2315) ...................... Glutethimide (2550) ...................... Nabilone (7379) ............................ Phencyclidine (7471) .................... Cocaine (9041) ............................. Codeine (9050) ............................. Diprenorphine (9058) .................... Oxycodone (9143) ........................ Hydromorphone (9150) ................. Diphenoxylate (9170) .................... Ecgonine (9180) ........................... Ethylmorphine (9190) ................... Hydrocodone (9193) ..................... Levorphanol (9220) ....................... Meperidine (9230) ......................... Methadone (9250) ........................ Morphine (9300) ........................... Thebaine (9333) ........................... Opium powdered (9639) ............... Levo-alphacetylmethadol (9648) .. Oxymorphone (9652) .................... Fentanyl (9801) ............................. I I I I I I I I I I I I II II II II II II II II II II II II II II II II II II II II II II II II II II II The company plans to import the listed controlled substances for sale to research facilities for drug testing and analysis. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a), and determined that the registration of Sigma Aldrich Manufacturing LLC., to import the basic classes of controlled substances is consistent with the public interest, and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Sigma Aldrich Manufacturing LLC., to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 E:\FR\FM\30JNN1.SGM 30JNN1 31314 Federal Register / Vol. 74, No. 124 / Tuesday, June 30, 2009 / Notices CFR 1301.34, the above named company is granted registration as an importer of the basic classes of controlled substances listed. Dated: June 23, 2009. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E9–15443 Filed 6–29–09; 8:45 am] Springfield, Virginia 22152; and must be filed no later than August 31, 2009. Dated: June 22, 2009. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E9–15442 Filed 6–29–09; 8:45 am] BILLING CODE 4410–09–P Dated: June 23, 2009. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E9–15447 Filed 6–29–09; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE BILLING CODE 4410–09–P Drug Enforcement Administration DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE Drug Enforcement Administration Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration Manufacturer of Controlled Substances; Notice of Application Pursuant to § 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on May 8, 2009, Chattem Chemicals Inc., 3801 St. Elmo Avenue, Building 18, Chattanooga, Tennessee 37409, made application by renewal to the Drug Enforcement Administration (DEA) as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II: Drug Schedule sroberts on PROD1PC70 with NOTICES6 4–Methoxyamphetamine (7411) ... Dihydromorphine (9145) ............... Amphetamine (1100) .................... Methamphetamine (1105) ............. Lisdexamfetamine (1205) ............. Methylphenidate (1724) ................ Pentobarbital (2270) ..................... Codeine (9050) ............................. Dihydrocodeine (9120) ................. Oxycodone (9143) ........................ Hydromorphone (9150) ................. Hydrocodone (9193) ..................... Meperidine (9230) ......................... Morphine (9300) ........................... Oripavine (9330) ........................... Thebaine (9333) ........................... Oxymorphone (9652) .................... Noroxymorphone (9668) ............... Alfentanil (9737) ............................ Remifentanil (9739) ...................... Sufentanil (9740) .......................... Fentanyl (9801) ............................. I I II II II II II II II II II II II II II II II II II II II II The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, VerDate Nov<24>2008 19:55 Jun 29, 2009 Jkt 217001 By Notice dated September 22, 2008, and published in the Federal Register on September 29, 2008, (73 FR 56612), Johnson Matthey Inc., Custom Pharmaceuticals Department, 2003 Nolte Drive, West Deptford, New Jersey 08066–1742, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Gamma Hydroxybutyric Acid (2010), a basic class of controlled substance listed in schedule I. The company plans to produce sodium oxybate for sale to customers. One objection was received; however, the objector is not registered with DEA as a bulk manufacturer of Gamma Hydroxybutyric Acid (GHB). DEA has determined that the objection received is without merit and does not warrant denial of the application. DEA has also determined that the Food and Drug Administration does not preclude the sale of GHB to other manufacturers for the development of generic GHB products. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Johnson Matthey Inc. to manufacture the listed basic class of controlled substance is consistent with the public interest at this time. DEA has investigated Johnson Matthey Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic class of controlled substance listed. PO 00000 Frm 00079 Fmt 4703 Sfmt 4703 Manufacturer of Controlled Substances; Notice of Registration By Notice dated June 19, 2008, and published in the Federal Register on June 27, 2008, (73 FR 36573), Norac Inc., 405 S. Motor Avenue, P.O. Box 577, Azusa, California 91702–3232, made application by letter to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of Gamma Hydroxybutyric Acid (2010), a basic class of controlled substance listed in schedule I. The company plans to manufacture the listed controlled substance in bulk for sale to its customers. One objection was received; however, the objector is not registered with DEA as a bulk manufacturer of Gamma Hydroxybutyric Acid (GHB). DEA has determined that the objection received is without merit and does not warrant denial of the application. DEA has also determined that the Food & Drug Administration does not preclude the sale of GHB to other manufacturers for the development of generic GHB products. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Norac Inc. to manufacture the listed basic class of controlled substance is consistent with the public interest at this time. DEA has investigated Norac Inc. to ensure that the company’s registration is consistent with the public interest. The investigation included the inspection and testing of the company’s physical security systems, verification of the company’s compliance with State and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823 and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic class of controlled substance listed. E:\FR\FM\30JNN1.SGM 30JNN1

Agencies

[Federal Register Volume 74, Number 124 (Tuesday, June 30, 2009)]
[Notices]
[Pages 31313-31314]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-15443]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By Notice dated February 23, 2009, and published in the Federal 
Register on March 2, 2009 (74 FR 9107), Sigma Aldrich Manufacturing 
LLC., 3500 Dekalb Street, St. Louis, Missouri 63118, made application 
by renewal to the Drug Enforcement Administration (DEA) to be 
registered as an importer of the basic classes of controlled substances 
listed in schedules I and II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Cathinone (1235)............................  I
Methcathinone (1237)........................  I
Aminorex (1585).............................  I
Gamma Hydroxybutyric Acid (2010)............  I
Methaqualone (2565).........................  I
Alpha-ethyltryptamine (7249)................  I
Ibogaine (7260).............................  I
Lysergic acid diethylamide (7315)...........  I
Marihuana (7360)............................  I
Tetrahydrocannabinols (7370)................  I
Mescaline (7381)............................  I
4-Bromo-2,5-dimethoxyamphetamine (7391).....  I
4-Bromo-2,5-dimethoxyphenethylamine (7392)..  I
4-Methyl-2,5-dimethoxyamphetamine (7395)....  I
2,5-Dimethoxyamphetamine (7396).............  I
3,4-Methylenedioxyamphetamine (7400)........  I
N-Hydroxy-3,4-methylenedioxyamphetamine       I
 (7402).
3,4-Methylenedioxy-N-ethylamphetamine (7404)  I
3,4-Methylenedioxymethamphetamine (MDMA)      I
 (7405).
4-Methoxyamphetamine (7411).................  I
Bufotenine (7433)...........................  I
Diethyltryptamine (7434)....................  I
Dimethyltryptamine (7435)...................  I
Psilocybin (7437)...........................  I
Psilocyn (7438).............................  I
1-[1-(2-Thienyl)cyclohexyl]piperdine (7470).  I
N-Benzylpiperazine (BZP) (7493).............  I
Heroin (9200)...............................  I
Normorphine (9313)..........................  I
Etonitazene (9624)..........................  I
Amphetamine (1100)..........................  II
Methamphetamine (1105)......................  II
Methylphenidate (1724)......................  II
Amobarbital (2125)..........................  II
Pentobarbital (2270)........................  II
Secobarbital (2315).........................  II
Glutethimide (2550).........................  II
Nabilone (7379).............................  II
Phencyclidine (7471)........................  II
Cocaine (9041)..............................  II
Codeine (9050)..............................  II
Diprenorphine (9058)........................  II
Oxycodone (9143)............................  II
Hydromorphone (9150)........................  II
Diphenoxylate (9170)........................  II
Ecgonine (9180).............................  II
Ethylmorphine (9190)........................  II
Hydrocodone (9193)..........................  II
Levorphanol (9220)..........................  II
Meperidine (9230)...........................  II
Methadone (9250)............................  II
Morphine (9300).............................  II
Thebaine (9333).............................  II
Opium powdered (9639).......................  II
Levo-alphacetylmethadol (9648)..............  II
Oxymorphone (9652)..........................  II
Fentanyl (9801).............................  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substances for 
sale to research facilities for drug testing and analysis.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a), and determined that the 
registration of Sigma Aldrich Manufacturing LLC., to import the basic 
classes of controlled substances is consistent with the public 
interest, and with United States obligations under international 
treaties, conventions, or protocols in effect on May 1, 1971, at this 
time. DEA has investigated Sigma Aldrich Manufacturing LLC., to ensure 
that the company's registration is consistent with the public interest. 
The investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21

[[Page 31314]]

CFR 1301.34, the above named company is granted registration as an 
importer of the basic classes of controlled substances listed.

    Dated: June 23, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E9-15443 Filed 6-29-09; 8:45 am]
BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.